Relmada Therapeutics, Inc. (RLMD)
4.52
+0.45
(+11.06%)
USD |
NASDAQ |
Sep 11, 16:00
4.62
+0.10
(+2.21%)
After-Hours: 20:00
Relmada Therapeutics Market Cap : 482.15M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 482.15M |
| September 10, 2026 | 434.15M |
| September 09, 2026 | 436.28M |
| September 08, 2026 | 453.35M |
| September 04, 2026 | 472.55M |
| September 03, 2026 | 466.15M |
| September 02, 2026 | 484.28M |
| September 01, 2026 | 475.75M |
| August 31, 2026 | 465.08M |
| August 28, 2026 | 461.88M |
| August 27, 2026 | 482.15M |
| August 26, 2026 | 485.35M |
| August 25, 2026 | 489.61M |
| August 24, 2026 | 488.55M |
| August 21, 2026 | 493.88M |
| August 20, 2026 | 494.95M |
| August 19, 2026 | 515.22M |
| August 18, 2026 | 517.35M |
| August 17, 2026 | 508.81M |
| August 14, 2026 | 512.02M |
| August 13, 2026 | 506.68M |
| August 12, 2026 | 503.48M |
| August 11, 2026 | 476.81M |
| August 10, 2026 | 484.28M |
| August 07, 2026 | 526.95M |
| Date | Value |
|---|---|
| August 06, 2026 | 572.82M |
| August 05, 2026 | 580.28M |
| August 04, 2026 | 583.48M |
| August 03, 2026 | 555.92M |
| July 31, 2026 | 556.97M |
| July 30, 2026 | 561.16M |
| July 29, 2026 | 539.14M |
| July 28, 2026 | 548.58M |
| July 27, 2026 | 545.43M |
| July 24, 2026 | 543.33M |
| July 23, 2026 | 545.43M |
| July 22, 2026 | 524.45M |
| July 21, 2026 | 555.92M |
| July 20, 2026 | 524.45M |
| July 17, 2026 | 549.62M |
| July 16, 2026 | 572.70M |
| July 15, 2026 | 651.37M |
| July 14, 2026 | 651.37M |
| July 13, 2026 | 676.54M |
| July 10, 2026 | 672.35M |
| July 09, 2026 | 682.84M |
| July 08, 2026 | 672.35M |
| July 07, 2026 | 672.35M |
| July 06, 2026 | 663.96M |
| July 02, 2026 | 658.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.612B |
| Corcept Therapeutics, Inc. | 12.17B |
| Veru, Inc. | 41.60M |
| Johnson & Johnson | 639.58B |
| Eli Lilly & Co. | 1.050T |
Market Cap Related Metrics
| Price to Book Value | 2.334 |
| Price | 4.52 |
| Earnings Yield | -20.58% |